Identification of the Risk of Remote Pulmonary Hypertension in Preterm Births.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to learn about the prevalence of pulmonary hypertension and right ventricular dysfunction in patients born prematurely, at birth and at a distance, and the association with the development of pulmonary bronchodysplasia, so that screening programs can be set up in the future and proper treatment can be initiated in a timely manner.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulmonary Hypertension in Extremely Preterm Infants

NCT05136235

Bronchopulmonary Dysplasia Pulmonary Hypertension Premature Birth

NOT_YET_RECRUITING NA

NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn

NCT04841070

Persistent Pulmonary Hypertension of the Newborn

COMPLETED NA

Early Prediction of Lung Injury in Preterm Infants Score

NCT07265583

Respiratory Distress Syndrome RDS Preterm Birth

RECRUITING

Cardio-respiratory Events in Preterm Infants During Transition

NCT04123691

Apnea of Prematurity Apneic Spells of Newborn Nos Patent Ductus Arteriosus +3 more

COMPLETED

Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children

NCT00005323

Lung Diseases Cardiovascular Diseases Defect, Congenital Heart +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to learn about the prevalence of pulmonary hypertension and right ventricular dysfunction in patients born prematurely, at birth and at a distance, and the association with the development of pulmonary bronchodysplasia, so that screening programs can be set up in the future and proper treatment can be initiated in a timely manner. Enrolled patients, should asymptomatic pulmonary hypertension be diagnosed, will be able to be taken to dedicated outpatient clinics and initiate appropriate treatment if indicated. The primary goal of this study is to evaluate the incidence of late pulmonary arterial hypertension and/or right ventricular dysfunction in a cohort of former preterm patients. The study will also provide a greater awareness of the epidemiology of pulmonary hypertension and right ventricular dysfunction in these patients and allow appropriate screening and follow-up to be planned.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PreTerm Neonate Pulmonary Hypertension of Newborn Right Ventricular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with prematurity with gestational age less than 30 weeks evaluated at outpatient clinics dedicated to neonatal follow-up of participating health care providers during the study data collection period.
* Obtaining informed consent.

Exclusion Criteria

* Prenatal or postnatal diagnosis of genetic disease;
* Concomitant presence of congenital heart disease except interatrial defect or patency of the ductus arteriosus;
* Concomitant presence of diaphragmatic hernia

Maximum Eligible Age

30 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No